Browsing by Author "Aksoy, Asude"
Now showing items 1-8 of 8
-
Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less
Ozaslan, Ersin; Karaca, Halit; Koca, Sinan; Sevinc, Alper; Hacioglu, Bekir; Ozkan, Metin; Ozcelik, Melike; Duran, Ayse O.; Hacibekiroglu, Ilhan; Yildiz, Yasar; Tanriverdi, Ozgur; Menekse, Serkan; Aksoy, Asude; Bozkurt, Oktay; Urvay, Semiha; Uysal, Mukremin; Demir, Hacer; Ciltas, Aydin; Dane, Faysal (LIPPINCOTT WILLIAMS & WILKINS, 2017)The objectives of this study were to compare progression-free survival (PFS) with somatostatin analog (SSA) versus chemotherapy (CTx) in first-line therapy and to determine the patient group in which these treatments were ... -
The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO
Yazici, Ozan; Ozdemir, Nuriye; Duran, Ayse Ocak; Menekse, Serkan; Ali, Mehmet; Sendur, Nahit; Karaca, Halit; Goksel, Gamze; Arpaci, Erkan; Hacibekiroglu, Ilhan; Bilgetekin, Irem; Kacan, Turgut; Ozkan, Metin; Aksoy, Sercan; Aksoy, Asude; Cokmert, Suna; Uysal, Mukremin; Elkiran, Emin Tamer; Cicin, Irfan; Buyukberber, Suleyman; Zengin, Nurullah (FUTURE MEDICINE LTD, 2016)Aim: To investigate the role of surgical resection of primary tumor on overall survival (OS) in advanced gastric cancer patients at the time of diagnosis. Patients & methods: The survival rates of metastatic gastric cancer ... -
Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma
Turan, Nedim; Benekli, Mustafa; Unal, Olcun Umit; Unek, Ilkay Tugba; Tastekin, Didem; Dane, Faysal; Algin, Efnan; Ulger, Sukran; Eren, Tulay; Topcu, Turkan Ozturk; Turkmen, Esma; Babacan, Nalan Akgul; Tufan, Gulnihal; Urakci, Zuhat; Ustaalioglu, Basak Oven; Uysal, Ozlem Sonmez; Ercelep, Ozlem Balvan; Taskoylu, Burcu Yapar; Aksoy, Asude; Canhoroz, Mustafa; Demirci, Umut; Dogan, Erkan; Berk, Veli; Balakan, Ozan; Ekinci, Ahmet Siyar; Uysal, Mukremin; Petekkaya, Ibrahim; Ozturk, Selcuk Cemil; Tonyali, Onder; Cetin, Bulent; Aldemir, Mehmet Naci; Helvaci, Kaan; Ozdemir, Nuriye; Oztop, Ilhan; Coskun, Ugur; Uner, Aytug; Ozet, Ahmet; Buyukberber, Suleyman (AME PUBL CO, 2015)Background: We examined the impact of adjuvant modalities on resected pancreatic and periampullary adenocarcinoma (PAC). Methods: A total of 563 patients who were curatively resected for PAC were retrospectively analyzed ... -
Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas
Cicin, Irfan; Ozatli, Tahsin; Turkmen, Esma; Ozturk, Turkan; Ozcelik, Melike; Cabuk, Devrim; Gokdurnali, Ayse; Balvan, Ozlem; Yildiz, Yasar; Seker, Metin; Ozdemir, Nuriye; Yapar, Burcu; Tanriverdi, Ozgur; Gunaydin, Yusuf; Menekse, Serkan; Oksuzoglu, Berna; Aksoy, Asude; Erdogan, Bulent; Hacioglu, M. Bekir; Arpaci, Erkan; Sevinc, Alper (GALENOS YAYINCILIK, 2016)Background: Prognostic factors and the standard treatment approach for gynaecological carcinosarcomas have not yet been clearly defined. Although carcinosarcomas are more aggressive than pure epithelial tumours, they are ... -
The prognostic value of lymph node ratio in patients with curatively resected pancreatic adenocarcinoma.
Turan, Nedim; Araz, Murat; Algin, Efnan; Unal, Olcun Umit; Benekli, Mustafa; Tastekin, Didem; Dane, Faysal; Unek, Tugba; Eren, Tulay; Turkmen, Esma; Kacan, Turgut; Aldemir, Mehmet Naci; Ekinci, Ahmet Siyar; Ulger, Sukran; Urakci, Zuhat; Aksoy, Asude; Tufan, Gulnihal; Coskun, Ugur; Ozet, Ahmet; Buyukberber, Suleyman (AMER SOC CLINICAL ONCOLOGY, 2015)… -
The role of the gastrectomy on survival in metastatic gastric cancer patients: A multicenter study of Anatolian Society of Medical Oncology (ASMO)
Yazici, Ozan; Ozdemir, Nuriye; Duran, Ayse Ocak; Menekse, Serkan; Sendur, Mehmet Ali Nahit; Karaca, Halit; Goksel, Gamze; Arpaci, Erkan; Eren, Tulay; Hacibekiroglu, Ilhan; Bilgetekin, Irem; Kacan, Turgut; Ozkan, Metin; Aksoy, Sercan; Aksoy, Asude; Zengin, Nurullah (AMER SOC CLINICAL ONCOLOGY, 2015)… -
What are the differences between young (25 years) and adults (> 25 years) colorectal cancer (CRC)? An Anatolian Society of Medical Oncology Study.
Kaplan, Muhammet Ali; Urakci, Zuhat; Gumus, Mahmut; Arslan, Ulku Yalcintas; Geredeli, Caglayan; Ozdemir, Nuriye; Koca, Dogan; Oruc, Zeynep; Uysal, Mukremin; Dane, Faysal; Sevinc, Alper; Seker, Mehmet Metin; Aksoy, Asude; Kucukoner, Mehmet; Pilanci, Kezban Nur; Topcu, Turkan Ozturk; Karaagac, Mustafa; Yildiz, Ramazan; Isikdogan, Abdurrahman (AMER SOC CLINICAL ONCOLOGY, 2015)… -
XELOX Plus Bevacizumab vs. FOLFIRI Plus Bevacizumab Treatment for First-line Chemotherapy in Metastatic Colon Cancer: a Retrospective Study of the Anatolian Society of Medical Oncology
Duran, Ayse Ocak; Karaca, Halit; Besiroglu, Mehmet; Bayoglu, Ibrahim Vedat; Menekse, Serkan; Yapici, Heves Surmeli; Yazilitas, Dogan; Bahceci, Aykut; Uysal, Mukremin; Sevinc, Alper; Hacibekiroglu, Ilhan; Aksoy, Asude; Tanriverdi, Ozgur; Arpaci, Erkan; Inanc, Mevlude; Dane, Faysal; Ozkan, Metin (ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)Background: XELOX plus bevacizumab (XELOX-Bev) and FOLFIRI plus Bevacizumab (FOLFIRI - Bev) treatments are an effective strategies patients with metastatic colorectal cancer (mCRC). The aim of this study was to compare ...